Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The global market for Anti-aging Drugs was estimated to be worth US$ 8823.1 million in 2023 and is forecast to a readjusted size of US$ 19560 million by 2030 with a CAGR of 11.9% during the forecast period 2024-2030
The industry's leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-aging Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-aging Drugs by region & country, by Type, and by Application.
The Anti-aging Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging Drugs.
Market Segmentation
By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech
Segment by Type:
Dermal Fillers
Botulinum Toxin
Others
Segment by Application
Hospital
Beauty Parlor
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-aging Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-aging Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Anti-aging Drugs Product Introduction
1.2 Global Anti-aging Drugs Market Size Forecast
1.2.1 Global Anti-aging Drugs Sales Value (2019-2030)
1.2.2 Global Anti-aging Drugs Sales Volume (2019-2030)
1.2.3 Global Anti-aging Drugs Sales Price (2019-2030)
1.3 Anti-aging Drugs Market Trends & Drivers
1.3.1 Anti-aging Drugs Industry Trends
1.3.2 Anti-aging Drugs Market Drivers & Opportunity
1.3.3 Anti-aging Drugs Market Challenges
1.3.4 Anti-aging Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-aging Drugs Players Revenue Ranking (2023)
2.2 Global Anti-aging Drugs Revenue by Company (2019-2024)
2.3 Global Anti-aging Drugs Players Sales Volume Ranking (2023)
2.4 Global Anti-aging Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Anti-aging Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Anti-aging Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anti-aging Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-aging Drugs
2.9 Anti-aging Drugs Market Competitive Analysis
2.9.1 Anti-aging Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-aging Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dermal Fillers
3.1.2 Botulinum Toxin
3.1.3 Others
3.2 Global Anti-aging Drugs Sales Value by Type
3.2.1 Global Anti-aging Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti-aging Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Anti-aging Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Anti-aging Drugs Sales Volume by Type
3.3.1 Global Anti-aging Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anti-aging Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Anti-aging Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Anti-aging Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Beauty Parlor
4.1.3 Others
4.2 Global Anti-aging Drugs Sales Value by Application
4.2.1 Global Anti-aging Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti-aging Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Anti-aging Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Anti-aging Drugs Sales Volume by Application
4.3.1 Global Anti-aging Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anti-aging Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Anti-aging Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Anti-aging Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anti-aging Drugs Sales Value by Region
5.1.1 Global Anti-aging Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti-aging Drugs Sales Value by Region (2019-2024)
5.1.3 Global Anti-aging Drugs Sales Value by Region (2025-2030)
5.1.4 Global Anti-aging Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Anti-aging Drugs Sales Volume by Region
5.2.1 Global Anti-aging Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anti-aging Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Anti-aging Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Anti-aging Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Anti-aging Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anti-aging Drugs Sales Value, 2019-2030
5.4.2 North America Anti-aging Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anti-aging Drugs Sales Value, 2019-2030
5.5.2 Europe Anti-aging Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-aging Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Anti-aging Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anti-aging Drugs Sales Value, 2019-2030
5.7.2 South America Anti-aging Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-aging Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Anti-aging Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-aging Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti-aging Drugs Sales Value
6.2.1 Key Countries/Regions Anti-aging Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anti-aging Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anti-aging Drugs Sales Value, 2019-2030
6.3.2 United States Anti-aging Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti-aging Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti-aging Drugs Sales Value, 2019-2030
6.4.2 Europe Anti-aging Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti-aging Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti-aging Drugs Sales Value, 2019-2030
6.5.2 China Anti-aging Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti-aging Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti-aging Drugs Sales Value, 2019-2030
6.6.2 Japan Anti-aging Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti-aging Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti-aging Drugs Sales Value, 2019-2030
6.7.2 South Korea Anti-aging Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti-aging Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-aging Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Anti-aging Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti-aging Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti-aging Drugs Sales Value, 2019-2030
6.9.2 India Anti-aging Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti-aging Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Information
7.1.2 Allergan Introduction and Business Overview
7.1.3 Allergan Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Allergan Anti-aging Drugs Product Offerings
7.1.5 Allergan Recent Development
7.2 Galderma
7.2.1 Galderma Company Information
7.2.2 Galderma Introduction and Business Overview
7.2.3 Galderma Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Galderma Anti-aging Drugs Product Offerings
7.2.5 Galderma Recent Development
7.3 LG Life Science
7.3.1 LG Life Science Company Information
7.3.2 LG Life Science Introduction and Business Overview
7.3.3 LG Life Science Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 LG Life Science Anti-aging Drugs Product Offerings
7.3.5 LG Life Science Recent Development
7.4 Merz Pharma
7.4.1 Merz Pharma Company Information
7.4.2 Merz Pharma Introduction and Business Overview
7.4.3 Merz Pharma Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merz Pharma Anti-aging Drugs Product Offerings
7.4.5 Merz Pharma Recent Development
7.5 Medytox
7.5.1 Medytox Company Information
7.5.2 Medytox Introduction and Business Overview
7.5.3 Medytox Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Medytox Anti-aging Drugs Product Offerings
7.5.5 Medytox Recent Development
7.6 Hugel
7.6.1 Hugel Company Information
7.6.2 Hugel Introduction and Business Overview
7.6.3 Hugel Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hugel Anti-aging Drugs Product Offerings
7.6.5 Hugel Recent Development
7.7 IMEIK
7.7.1 IMEIK Company Information
7.7.2 IMEIK Introduction and Business Overview
7.7.3 IMEIK Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 IMEIK Anti-aging Drugs Product Offerings
7.7.5 IMEIK Recent Development
7.8 Haohai Bio
7.8.1 Haohai Bio Company Information
7.8.2 Haohai Bio Introduction and Business Overview
7.8.3 Haohai Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Haohai Bio Anti-aging Drugs Product Offerings
7.8.5 Haohai Bio Recent Development
7.9 Daewoong Pharmaceutical
7.9.1 Daewoong Pharmaceutical Company Information
7.9.2 Daewoong Pharmaceutical Introduction and Business Overview
7.9.3 Daewoong Pharmaceutical Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Daewoong Pharmaceutical Anti-aging Drugs Product Offerings
7.9.5 Daewoong Pharmaceutical Recent Development
7.10 Bloomage
7.10.1 Bloomage Company Information
7.10.2 Bloomage Introduction and Business Overview
7.10.3 Bloomage Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bloomage Anti-aging Drugs Product Offerings
7.10.5 Bloomage Recent Development
7.11 Suneva Medical
7.11.1 Suneva Medical Company Information
7.11.2 Suneva Medical Introduction and Business Overview
7.11.3 Suneva Medical Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Suneva Medical Anti-aging Drugs Product Offerings
7.11.5 Suneva Medical Recent Development
7.12 SciVision Biotech
7.12.1 SciVision Biotech Company Information
7.12.2 SciVision Biotech Introduction and Business Overview
7.12.3 SciVision Biotech Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 SciVision Biotech Anti-aging Drugs Product Offerings
7.12.5 SciVision Biotech Recent Development
8 Industry Chain Analysis
8.1 Anti-aging Drugs Industrial Chain
8.2 Anti-aging Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-aging Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Anti-aging Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech
*If Applicable.